Netherlands· NL-dceb53ef8476
Mycospor, creme o/w 10 mg/g
A bifonazole product containing bifonazol, registered in Netherlands by Bayer B.V.. The same ATC class is registered in 10 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Bifonazole is registered in 10 of 19 countries.
Countries holding a registration under ATC D01AC10 (bifonazole), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 5 of them publish a price we can compare per daily dose
Bifonazole · ATC D01AC10
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- BIFONAZOL
- Manufacturer
- Bayer B.V.
- Country
- Netherlands (NL)
- ATC code
- D01AC10
- ATC class
- Bifonazole
- Defined daily dose
- 10 mg, T
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id10364
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bifonazole in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandCanesporInPharm Sp. z o.o.
- SpainCANESMYCOSPOR 10 mg/g CREMABayer Hispania S.L.
- CzechiaCANESPOR 1X DENNĚBAYER s.r.o., Praha
- FinlandCanesporBayer Oy
- IrelandCanespor 10 mg/g creamBayer Limited
- BelgiumCanestene Derm 1 %Bayer
- FranceAMYCOR 1 POUR CENT, crème pour application localeMERCK SANTE
- GermanyBifonDermapharm Ag
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Canesten
- Belgium · Canestene Derm
- Bulgaria · Бифоназол Абр, Канеспор
- Czechia · Canespor 1x Denně
- Germany · Bifon, Bifonazol Aristo
- Spain · Canesmycospor, Canespie
- Finland · Canespor
- France · Amycor, Bifonazole Gerda
- United Kingdom (Northern Ireland) · Canesten Once Daily, Canesten Once Daily Athlete’s Foot
- Greece · Fungiderm 1% W/W Κρέμα
- Croatia · Canespor
- Hungary · Canesten Plus
- Ireland · Canespor
- Italy · Azolmen, Canesten Unidie
- Luxembourg · Canestene Derm
- Poland · Canespor, Steper Pro
- Portugal · Bifonazol Farmoz, Canesten Unidia
- Romania · Biazol, Canespor
- Slovenia · Canespor
- Slovakia · Canespor
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/97fa66e3-1bfd-4bdd-9703-602f2ca37f4d GET /v1/drugs/97fa66e3-1bfd-4bdd-9703-602f2ca37f4d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Crème",
"route": "Cutaan gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h10364_smpc.pdf",
"strength": null,
"atc_label": "Bifonazole",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg10364",
"excipients": [
"BENZYLALCOHOL (E 1519)",
"CETOSTEARYLALCOHOL",
"CETYLESTERS WAS",
"OCTYLDODECANOL",
"POLYSORBAAT 60 (E 435)",
"SORBITANMONOSTEARAAT (E 491)",
"WATER, GEZUIVERD"
],
"substances": [
"BIFONAZOL"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h10364.pdf",
"authorised_at": "1984/11/14",
"procedure_number": null,
"dispensing_status": "Uitsluitend apotheek of drogist",
"registration_number": "10364",
"additional_monitoring": "N"
}See everything about bifonazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.